B. Quantifiable deliverables (The meanings of deliverables, output, outcome, etc. will be as given in Annexure 11): for the Consortium
a. Scientific
Objective 1: Isolation of bio-active compounds from five common weeds used as medicinal in Indian Systems of Medicine from rice, sugarcane and cotton based cropping systems of Andhra Pradesh
S. No. |
Activity |
I (one year three months) Year |
II Year |
Outcome |
Deliverables |
Output |
Deliverables |
Output |
1. |
Identification of commercially viable five weed species using as medicinal plants |
Identification of five medicinal weed species |
Selection of five weeds |
|
|
Five commercially viable medicinal weeds and database development |
2. |
Bio-assay guided isolation and purification of active molecules / compounds at different growth stages of the weed in different cropping systems and different seasons |
Isolation of bioactive compounds |
Identification of bioactive molecules |
Isolation of bioactive compounds |
Identification of bioactive molecules |
Bioactive molecules
Adds knowledge to ITKS |
B. Quantifiable deliverables (The meanings of deliverables, output, outcome, etc. will be as given in Annexure 11): for the Consortium
a. Scientific
Objective 2: Chemical identification of bio-active molecules and its derivatives.
S. No. |
Activity |
II year |
III Year |
Outcome |
Deliverables |
Output |
Deliverables |
Output |
1. |
Chemical identification of bioactive molecules using spectral data |
Isolation of bioactive compounds |
Identification of bioactive molecules |
|
|
Bioactive molecules can be structured |
2. |
Semi-synthesis of active derivatives |
Derivatives |
Active derivatives |
Derivatives |
Active derivatives |
Bioactive derivatives can be structured |
B. Quantifiable deliverables (The meanings of deliverables, output, outcome, etc. will be as given in Annexure 11): for the Consortium
a. Scientific
Objective 3: Validation of bio-active molecules
S. No. |
Activity |
II year |
III Year |
Outcome |
Deliverables |
Output |
Deliverables |
Output |
1. |
In-vitro and In-vivo validation of efficacy of bioactive compound (s) using appropriate test organisms |
Identification of different pharmacological activities of lead molecules on a scientific basis |
Lead molecules will be identified |
Identification of different pharmacological activities of lead molecules on a scientific basis |
Lead molecules will be identified |
Pharmacologically validated bioactive molecules can be identified |
B. Quantifiable deliverables (The meanings of deliverables, output, outcome, etc. will be as given in Annexure 11): for the Consortium
a. Scientific
Objective 4: Selection of highly bio-active rich genotypes of the five identified species
S. No. |
Activity |
II year |
III Year |
Outcome |
Deliverables |
Output |
Deliverables |
Output |
1. |
Selection of highly bioactive rich genotype from each species and their chemotyping |
|
|
Identification of highly bioactive rich genotype from each species |
Highly bioactive rich genotype from each species |
Highly potent genotypes from each species and their chemotying will be identified |
2. |
Assessment of post-harvesting handling techniques for preserving the medicinal properties of the identified weeds at the farm level. |
Derivatives |
Active derivatives |
Developing farmers friendly post-harvesting techniques |
A simple farm level processing techniques |
Farmer’s friendly post-harvesting techniques |